These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22104148)

  • 21. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
    Manikannan R; Venkatesan R; Muthusubramanian S; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6920-4. PubMed ID: 20970331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
    Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
    Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Khalilullah H; Bakht MA; Hassan MZ
    Eur J Med Chem; 2011 Nov; 46(11):5694-7. PubMed ID: 21978838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
    Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M
    Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
    Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
    Mohan Krishna K; Inturi B; Pujar GV; Purohit MN; Vijaykumar GS
    Eur J Med Chem; 2014 Sep; 84():516-29. PubMed ID: 25055342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.
    Dessalew N; Singh SK
    Med Chem; 2008 Jul; 4(4):313-21. PubMed ID: 18673142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents.
    Wang A; Yang Y; Jun Y; Wang B; Lv K; Liu M; Guo H; Lu Y
    Bioorg Med Chem; 2018 May; 26(8):2073-2084. PubMed ID: 29551372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-(adamantan-1-yl) group containing quinolines.
    Nayyar A; Patel SR; Shaikh M; Coutinho E; Jain R
    Eur J Med Chem; 2009 May; 44(5):2017-29. PubMed ID: 19022537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
    Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
    J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus.
    Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J
    SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents.
    Telvekar VN; Bairwa VK; Satardekar K; Bellubi A
    Bioorg Med Chem Lett; 2012 Jan; 22(1):649-52. PubMed ID: 22079026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
    Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.